リラクミンＳｅ（エスイー）: notification withdrawn

Notification number

D411

Type

Processed food (tablets, capsules and similar forms)

Published status

Notification withdrawn

Notifier

株式会社リラクル

Notification date

2018-12-26

Modification date

2024-03-01

Withdrawal date

2026-03-31

Notification under the company’s responsibility, without prior review by the Japanese state. The Japanese category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

• Information

  A claim declared in Japan is not an authorised health claim in the European Union.

  CAA, Japan Foods with Function Claims notifications, retrieval date unknown.

  Source : Agence de la consommation du Japon (CAA), https://www.fld.caa.go.jp/caaks/s/cssc01/. Données traitées par CompoAtlas à partir de l'export officiel ; cette présentation est celle de CompoAtlas et n'est pas publiée telle quelle par l'État japonais. Public Data License 1.0.

  Public Data License 1.0 (公共データ利用規約 第1.0版), compatible CC BY 4.0

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Daily quantities are reproduced as declared, without estimation or conversion. A quantity is associated with an ingredient only when the name and match are unambiguous. Japanese names and texts are retained without translation. No comparison with dose limits is performed.

Name (original Japanese text)

ラフマ葉抽出物含有加工食品

Declared claim (original Japanese text)

本品にはラフマ由来ヒペロシド、ラフマ由来イソクエルシトリンが含まれます。ラフマ由来ヒペロシド、ラフマ由来イソクエルシトリンには睡眠の質（眠りの深さ）の向上に役立つことが報告されています。

Precautions (original Japanese text)

多量摂取により疾病が治癒したり、より健康が増進するものではありません。一日摂取目安量を守ってください。乳幼児の手の届かない所に保管してください。薬の服用あるいは通院中の方は、医師とご相談のうえ、お召し上がりください。

Reason for withdrawal (original Japanese text)

消費者庁において機能性表示食品の要件を欠くと確認した届出

Raw materials of functional ingredients (original Japanese text)

ラフマ葉抽出物

Recommended daily intake (original Japanese text)

2粒

Method of consumption (original Japanese text)

一日2粒を目安に就寝前などに水またはぬるま湯とともにお召し上がりください。

Ingredient names for daily quantities (original Japanese text)

ラフマ由来ヒペロシド 、ラフマ由来イソクエルシトリン

Declared daily quantities (original Japanese text)

ラフマ由来ヒペロシド ：1mg 、ラフマ由来イソクエルシトリン： 1mg

A claim declared in Japan is not an authorised health claim in the European Union. See the health claims register.

Original register data

Official source

View the official register, number D411

Source : Agence de la consommation du Japon (CAA), https://www.fld.caa.go.jp/caaks/s/cssc01/. Données traitées par CompoAtlas à partir de l'export officiel ; cette présentation est celle de CompoAtlas et n'est pas publiée telle quelle par l'État japonais. Public Data License 1.0.

Public Data License 1.0 (公共データ利用規約 第1.0版), compatible CC BY 4.0

List in the official revision dated 1 March 2024 (register: CAA, Japan Foods with Function Claims notifications).

List recorded in 2024. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.